OCC - オプティカル・ケ―ブル (Optical Cable Corporation)

OCCのニュース

   Fiber Optics Market to Garner USD 14,194 Million at an 8.4% CAGR by 2026 - Report by Market Research Future (MRFR)  2021/06/21 17:00:36 Benzinga
New York, US, June 21, 2021 (GLOBE NEWSWIRE) -- Market Overview: According to a comprehensive research report by Market Research Future (MRFR), "Global Fiber Optics Market information by Mode Type, Application, End-User and Region - Forecast till 2026" , market size is expected to grow from USD 8,130.0 million in 2019 to USD 14,194.0 million by 2026, at a compound annual growth rate of 8.4%. Market Scope: With developments in end-use applications across numerous business sectors and the migration from traditional server-based operations to cloud-based platforms, the demand for high bandwidth connectivity is increasing. This has reduced the need for physical computing resources since cloud platforms provide benefits such as lower operating costs, improved data security, no need to invest in and maintain expensive IT infrastructure, easy application deployment, and accessibility to anyone in remote locations. Furthermore, the need for 5G connectivity among firms to implement industrial IoT is growing.
   Proactive news headlines including Volt Resources, Orthocell, Zelira Therapeutics and Tempus Resources  2021/06/21 09:43:00 Intrado Digital Media
Sydney, June 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
   S&P/ASX 200 drops 1.68% as US signals sooner than expected interest rates hike  2021/06/21 03:05:00 Proactive Investors Australia
S&P/ASX 200 (INDEXASX:XJO) slipped 1.68% to 7,245 points by about 12.52 pm following a weak lead from US markets over the weekend. The index is on track for its worst daily decline since February 26 this year when it dropped 2.35%. Wall Street markets fell as much as 1.6% on Friday over concerns that US interest rates could begin to lift sooner than expected as the economy continues to show strong signs of recovery. Locally, stocks were lower across the board with all sectors in negative territory. Financials slump Financials were the worst performers with a significant drop across the big four banks. Commonwealth Bank (ASX:CBA) dipped 4.5% after agreeing to sell its home and motor insurance business to South African based insurance group, Hollard Group, for $625 million. Oil prices rose over the weekend with Brent crude up 0.6% to US$73.51 a barrel, while WTI crude is up 0.8% to US$71.64 a barrel. Iron ore prices slipped by 0.9% to US$218.90 a tonne while spot gold fell 0.5% to US$1764.19 per ounce and was at its lowest since mid-April.
   Why the Orthocell (ASX:OCC) share price is flying higher today  2021/06/21 02:04:00 The Motley Fool Australia
Orthocell reports promising results on nerve repair for patients following serious injury. The post Why the Orthocell (ASX:OCC) share price is flying higher today appeared first on The Motley Fool Australia .
   Orthocell unveils positive CelGro® nerve regeneration results in quadriplegic patients  2021/06/21 01:57:00 Proactive Investors Australia
Orthocell Ltd''s (ASX:OCC) shares jumped this morning after tabling positive nerve regeneration results one year on from a study testing its nerve repair candidate on quadriplegic patients. The regenerative medicine company conducted the first interim data readout of all patients in the CelGro® clinical trial 12 months after the study concluded. Promisingly, 25 out of 33, or 75.8%, of all nerve repairs that took place during the study resulted in functional recovery. Now it has the 12-month data at hand, Orthocell is preparing for discussions with the Food and Drug Administration (FDA) to prepare CelGro for the approval pathway. In addition, the ASX-lister is in talks with US insurance companies and key opinion leaders to finalise its commercialisation approach. Shares were as much as 8.3% higher this morning to A$0.655, a new high of almost six years, while the company''s market cap pre-open was approximately A$115.2 million. Increases success of nerve transfer surgery Orthocell managing director Paul Anderson said: Consistently returning function to paralysed upper limbs is the primary goal in this study. I am delighted by the 12-month follow-up results, our most complete data set to date, demonstrating higher quality outcomes, improved predictability and consistency of return of muscle function following CelGro nerve regeneration treatment. Orthopaedic nerve specialist and clinical trial lead Dr Alex OBeirne commented: We are now seeing a consistent return of arm and hand function following nerve transfer surgery with CelGro.
   Fiber Optics Market to Garner USD 14,194 Million at an 8.4% CAGR by 2026 - Report by Market Research Future (MRFR)  2021/06/21 17:00:36 Benzinga
New York, US, June 21, 2021 (GLOBE NEWSWIRE) -- Market Overview: According to a comprehensive research report by Market Research Future (MRFR), "Global Fiber Optics Market information by Mode Type, Application, End-User and Region - Forecast till 2026" , market size is expected to grow from USD 8,130.0 million in 2019 to USD 14,194.0 million by 2026, at a compound annual growth rate of 8.4%. Market Scope: With developments in end-use applications across numerous business sectors and the migration from traditional server-based operations to cloud-based platforms, the demand for high bandwidth connectivity is increasing. This has reduced the need for physical computing resources since cloud platforms provide benefits such as lower operating costs, improved data security, no need to invest in and maintain expensive IT infrastructure, easy application deployment, and accessibility to anyone in remote locations. Furthermore, the need for 5G connectivity among firms to implement industrial IoT is growing.
   Proactive news headlines including Volt Resources, Orthocell, Zelira Therapeutics and Tempus Resources  2021/06/21 09:43:00 Intrado Digital Media
Sydney, June 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
   S&P/ASX 200 drops 1.68% as US signals sooner than expected interest rates hike  2021/06/21 03:05:00 Proactive Investors Australia
S&P/ASX 200 (INDEXASX:XJO) slipped 1.68% to 7,245 points by about 12.52 pm following a weak lead from US markets over the weekend. The index is on track for its worst daily decline since February 26 this year when it dropped 2.35%. Wall Street markets fell as much as 1.6% on Friday over concerns that US interest rates could begin to lift sooner than expected as the economy continues to show strong signs of recovery. Locally, stocks were lower across the board with all sectors in negative territory. Financials slump Financials were the worst performers with a significant drop across the big four banks. Commonwealth Bank (ASX:CBA) dipped 4.5% after agreeing to sell its home and motor insurance business to South African based insurance group, Hollard Group, for $625 million. Oil prices rose over the weekend with Brent crude up 0.6% to US$73.51 a barrel, while WTI crude is up 0.8% to US$71.64 a barrel. Iron ore prices slipped by 0.9% to US$218.90 a tonne while spot gold fell 0.5% to US$1764.19 per ounce and was at its lowest since mid-April.
   Why the Orthocell (ASX:OCC) share price is flying higher today  2021/06/21 02:04:00 The Motley Fool Australia
Orthocell reports promising results on nerve repair for patients following serious injury. The post Why the Orthocell (ASX:OCC) share price is flying higher today appeared first on The Motley Fool Australia .
   Orthocell unveils positive CelGro® nerve regeneration results in quadriplegic patients  2021/06/21 01:57:00 Proactive Investors Australia
Orthocell Ltd''s (ASX:OCC) shares jumped this morning after tabling positive nerve regeneration results one year on from a study testing its nerve repair candidate on quadriplegic patients. The regenerative medicine company conducted the first interim data readout of all patients in the CelGro® clinical trial 12 months after the study concluded. Promisingly, 25 out of 33, or 75.8%, of all nerve repairs that took place during the study resulted in functional recovery. Now it has the 12-month data at hand, Orthocell is preparing for discussions with the Food and Drug Administration (FDA) to prepare CelGro for the approval pathway. In addition, the ASX-lister is in talks with US insurance companies and key opinion leaders to finalise its commercialisation approach. Shares were as much as 8.3% higher this morning to A$0.655, a new high of almost six years, while the company''s market cap pre-open was approximately A$115.2 million. Increases success of nerve transfer surgery Orthocell managing director Paul Anderson said: Consistently returning function to paralysed upper limbs is the primary goal in this study. I am delighted by the 12-month follow-up results, our most complete data set to date, demonstrating higher quality outcomes, improved predictability and consistency of return of muscle function following CelGro nerve regeneration treatment. Orthopaedic nerve specialist and clinical trial lead Dr Alex OBeirne commented: We are now seeing a consistent return of arm and hand function following nerve transfer surgery with CelGro.
   Optical Cable Corp. to Host Earnings Call  2021/03/15 12:15:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / March 15, 2021 / Optical Cable Corp. (NASDAQ:OCC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on March 15, 2021 at 10:00 AM Eastern Time.
   Stellar start for IPO EZZ Life Science (ASX:EZZ): ASX closed 0.8% higher  2021/03/03 06:00:10 Bourse Data
03 Mar 2021 - It has been a positive day of trade for the Australian share market. At the closing bell the S&P/ASX 200 index closed 56 points up or 0.8% higher to finish at 6,818. Regenerative medicine company Orthocell (ASX:OCC) has received notification from the Australian Government Department of Health that CelGro Dental has been included on the Australian Prostheses List.
   Fiber Optics Cable Market Analysis 2021-2027: By Key Players - Hitachi Cable Ltd., Optical Cable Corporation, Prysmian Group  2021/02/17 14:09:37 OpenPR
Latest Published Report by Allied Market Research Titled,”Fiber Optics Cable Market by Cable Type (Single-mode and Multi-mode), by Material Type (Glass and Plastics), and by Application (Communication, Power Transmission, Sensor, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027”. The
   Orthocell Receives US Market Clearance  2021/01/15 05:21:00 Business Wire
PERTH, Australia--(BUSINESS WIRE)---- $OCC #ASX--Australian-based regenerative medicine company, Orthocell Ltd (ASX:OCC, “Orthocell” or the “Company”), has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market. Orthocell Managing Director, Paul Anderson, said: “US approval is a significant inflection point for our Company, and we are now primed to partner and distribute this product. I look forward to working with our leadi
   Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device  2021/01/14 18:00:00 BioWorld
PERTH, Australia – Perth-based regenerative medicine company Orthocell Ltd. saw its shares rise 27% on the heels of its first U.S. approval for its collagen medical device for dental guided bone and soft tissue regeneration applications.

calendar